Targeting neurotrophin-3 and its dependence receptor tyrosine kinase receptor C: A new antitumoral strategy

Expert Opinion on Therapeutic Targets

Volumn 15, Issue 7, 2011, Pages 847-858

  Tauszig Delamasure, Servane ^a   Bouzas Rodriguez, Jimena ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

apoptosis; dependence receptor; neuroblastoma; neurotrophin; NT 3; TrkC

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CEP 2563; CEP 751; LESTAURTINIB; NEUROTROPHIN 3; NEUROTROPHIN 3 RECEPTOR; PROTEIN TYROSINE KINASE A; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER INHIBITION; CANCER STAGING; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG TARGETING; HUMAN; MEDULLOBLASTOMA; METASTASIS; NEUROBLAST; NEUROBLASTOMA; NONHUMAN; PANCREAS CARCINOMA; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; CHILD; HUMANS; NEUROTROPHIN 3; ONCOGENES; RECEPTOR, TRKC;

EID: 79958274353     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2011.575361     Document Type: Review

References (63)

1. Grant SK. Therapeutic protein kinase inhibitors. Cell Mol Life Sci 2009;66:1163-77
2. Cotter TG. Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 2009;9:501-7
3. Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet 2007;369:2106-20 (Pubitemid 46935947)
4. Nakagawara A. Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett 2001;169:107-14 (Pubitemid 32595557)
5. Nikoletopoulou V, Lickert H, Frade JM, et al. Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not. Nature 2010;467:59-63
6. Tauszig-Delamasure S, Yu LY, Cabrera JR, et al. The TrkC receptor induces apoptosis when the dependence receptor notion meets the neurotrophin paradigm. Proc Natl Acad Sci USA 2007;104:13361-6 (Pubitemid 47293950)
7. Bredesen DE, Mehlen P, Rabizadeh S. Receptors that mediate cellular dependence. Cell Death Differ 2005;12:1031-43 (Pubitemid 41065421)
8. Goldschneider D, Mehlen P. Dependence receptors: a new paradigm in cell signaling and cancer therapy. Oncogene 2010;29:1865-82
9. Rabizadeh S, Oh J, Zhong LT, et al. Induction of apoptosis by the low-affinity NGF receptor. Science 1993;261:345-8 (Pubitemid 23281003)
10. Ellerby LM, Hackam AS, Propp SS, et al. Kennedy's disease: caspase cleavage of the androgen receptor is a crucial event in cytotoxicity. J Neurochem 1999;72:185-95 (Pubitemid 29013892)
11. Mehlen P, Rabizadeh S, Snipas SJ, et al. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 1998;395:801-4 (Pubitemid 28485447)
12. Llambi F, Causeret F, Bloch-Gallego E, Mehlen P. Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. EMBO J 2001;20:2715-22 (Pubitemid 32938556)
13. Matsunaga E, Tauszig-Delamasure S, Monnier PP, et al. RGM and its receptor neogenin regulate neuronal survival. Nat Cell Biol 2004;6:749-55 (Pubitemid 39144480)
14. Thibert C, Teillet MA, Lapointe F, et al. Inhibition of neuroepithelial patched-induced apoptosis by sonic hedgehog. Science 2003;301:843-6 (Pubitemid 36962627)
15. Stupack DG, Puente XS, Boutsaboualoy S, et al. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol 2001;155:459-70 (Pubitemid 34289336)
16. Bordeaux MC, Forcet C, Granger L, et al. The RET proto-oncogene i nduces apoptosis: a novel mechanism for Hirschsprung disease. EMBO J 2000;19:4056-63 (Pubitemid 30608544)
17. Foveau B, Leroy C, Ancot F, et al. Amplification of apoptosis through sequential caspase cleavage of the MET tyrosine kinase receptor. Cell Death Differ 2007;14:752-64 (Pubitemid 46444513)
18. Tulasne D, Deheuninck J, Lourenco FC, et al. Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage. Mol Cell Biol 2004;24:10328-39 (Pubitemid 39507870)
19. Mourali J, Benard A, Lourenco FC, et al. Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage. Mol Cell Biol 2006;26:6209-22 (Pubitemid 44204538)
20. Furne C, Ricard J, Cabrera JR, et al. EphrinB3 is an anti-apoptotic ligand that inhibits the dependence receptor functions of EphA4 receptors during adult neurogenesis. Biochim Biophys Acta 2009;1793:231-8
21. Barde YA, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982;1:549-53
22. Leibrock J, Lottspeich F, Hohn A, et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature 1989;341:149-52 (Pubitemid 19222776)
23. Hohn A, Leibrock J, Bailey K, Barde YA. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 1990;344:339-41
24. Maisonpierre PC, Belluscio L, Squinto S, et al. Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science 1990;247:1446-51
25. Hallbook F, Ibanez CF, Persson H. Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 1991;6:845-58
26. Bibel M, Barde YA. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 2000;14:2919-37
27. Barbacid M. Neurotrophic factors and their receptors. Curr Opin Cell Biol 1995;7:148-55
28. Hamburger V. The history of the discovery of the nerve growth factor. J Neurobiol 1993;24:893-7 (Pubitemid 23178778)
29. Hamburger V, Levi-Montalcini R. Proliferation, differentiation and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions. J Exp Zool 1949;111:457-501
30. Levi-Montalcini R. The development to the acoustico-vestibular centers in the chick embryo in the absence of the afferent root fibers and of descending fiber tracts. J Comp Neurol 1949;91:209-41, illustrations, include three plates
31. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 2006;6:449-58
32. Fitamant J, Guenebeaud C, Coissieux MM, et al. Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer. Proc Natl Acad Sci USA 2008;105:4850-5 (Pubitemid 351753835)
33. Delloye-Bourgeois C, Brambilla E, Coissieux MM, et al. Interference with netrin-1 and tumor cell death in non-small cell lung cancer. J Natl Cancer Inst 2009;101:237-47
34. Delloye-Bourgeois C, Fitamant J, Paradisi A, et al. Netrin-1 acts as a survival factor for aggressive neuroblastoma. J Exp Med 2009;206:833-47
35. Brodeur GM, Minturn JE, Ho R, et al. Trk receptor expression and inhibition in neuroblastomas. Clin Cancer Res 2009;15:3244-50
36. Rydén M, Sehgal R, Dominici C, et al. Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis. Br J Cancer 1996;74:773-9 (Pubitemid 26300770)
37. Svensson T, Ryden M, Schilling FH, et al. Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma. Eur J Cancer 1997;33:2058-63 (Pubitemid 28123454)
38. Yamashiro DJ, Nakagawara A, Ikegaki N, et al. Expression of TrkC in favorable human neuroblastomas. Oncogene 1996;12:37-41 (Pubitemid 26041238)
39. Brodeur GM, Nakagawara A, Yamashiro DJ, et al. Expression of TrkA, TrkB and TrkC in human neuroblastomas. J Neurooncol 1997;31:49-55 (Pubitemid 27077709)
40. Nakagawara A, Brodeur GM. Role of neurotrophins and their r eceptors in human neuroblastomas: a primary culture study. Eur J Cancer 1997;33:2050-3 (Pubitemid 28123452)
41. Bouzas-Rodriguez J, Cabrera JR, Delloye-Bourgeois C, et al. Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis. J Clin Invest 2010;120:850-8
42. Wang T, Yu D, Lamb ML. Trk kinase inhibitors as new treatments for cancer and pain. Expert Opin Ther Pat 2009;19:305-19
43. Thiele CJ, Li Z, McKee AE. On Trk - the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin Cancer Res 2009;15:5962-7
44. Marshall JL, Kindler H, Deeken J, et al. Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor. Invest New Drugs 2005;23:31-7 (Pubitemid 39505949)
45. Knapper S, Burnett AK, Littlewood T, et al. A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy. Blood 2006;108:3262-70
46. Chan E, Mulkerin D, Rothenberg M, et al. A phase I trial of CEP-701 + gemcitabine in patients with advanced adenocarcinoma of the pancreas. Invest New Drugs 2008;26:241-7
47. Weeraratna AT, Dalrymple SL, Lamb JC, et al. Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells. Clin Cancer Res 2001;7:2237-45 (Pubitemid 32751620)
48. Evans AE, Kisselbach KD, Yamashiro DJ, et al. Antitumor activity of CEP-751 (KT-6587) on human neuroblastoma and medulloblastoma xenografts. Clin Cancer Res 1999;5:3594-602
49. Miknyoczki SJ, Chang H, Klein-Szanto A, et al. The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma. Clin Cancer Res 1999;5:2205-112
50. Yamamoto M, Sobue G, Yamamoto K, et al. Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneural tissues. Neurochem Res 1996;21:929-38
51. Donovan MJ, Miranda RC, Kraemer R, et al. Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am J Pathol 1995;147:309-24
52. Hiltunen JO, Arumae U, Moshnyakov M, Saarma M. Expression of mRNAs for neurotrophins and their receptors in developing rat heart. Circ Res 1996;79:930-9 (Pubitemid 26359234)
53. Scarisbrick IA, Jones EG, Isackson PJ. Coexpression of mRNAs for NGF, BDNF, and NT-3 in the cardiovascular system of the pre- and postnatal rat. J Neurosci 1993;13:875-93 (Pubitemid 23067578)
54. Lommatzsch M, Quarcoo D, Schulte-Herbruggen O, et al. Neurotrophins in murine viscera: a dynamic pattern from birth to adulthood. Int J Dev Neurosci 2005;23:495-500 (Pubitemid 41138140)
55. Schramm A, Schulte JH, Astrahantseff K, et al. Biological effects of TrkA and TrkB receptor signaling in neuroblastoma. Cancer Lett 2005;228:143-53 (Pubitemid 41188436)
56. Harel L, Costa B, Fainzilber M. On the death Trk. Dev Neurobiol 2010;70:298-303
57. Schulte JH, Horn S, Schlierf S, et al. MicroRNAs in the pathogenesis of neuroblastoma. Cancer Lett 2009;274:10-15
58. Sinnappah-Kang ND, Kaiser AJ, Blust BE, et al. Heparanase, TrkC and p75NTR: their functional involvement in human medulloblastoma cell invasion. Int J Oncol 2005;27:617-26
59. Sinnappah-Kang ND, Kaiser AJ, Blust BE, et al. Heparanase expression and TrkC/p75NTR ratios in human medulloblastoma. Clin Exp Metastasis 2006;23:55-63 (Pubitemid 44576779)
60. Marchetti D, Nicolson GL. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations. Adv Enzyme Regul 1997;37:111-34 (Pubitemid 27371558)
61. Tanikawa C, Matsuda K, Fukuda S, et al. p53RDL1 regulates p53-dependent apoptosis. Nat Cell Biol 2003;5:216-23 (Pubitemid 36322248)
62. Wang H, Ozaki T, Shamim Hossain M, et al. A newly identified dependence receptor UNC5H4 is induced during DNA damage-mediated apoptosis and transcriptional target of tumor suppressor p53. Biochem Biophys Res Commun 2008;370:594-8
63. Cañibano C, Rodriguez NL, Saez C, et al. The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth. EMBO J 2007;26:2015-28 (Pubitemid 46625783)